Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
China flag China · Delayed Price · Currency is CNY
3.230
-0.050 (-1.52%)
Sep 10, 2026, 1:45 PM CST

SHE:300267 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
884.31897.4698.54744.35764.67761.56
Trading Asset Securities
20901200.12114.12-
Cash & Short-Term Investments
904.31987.4818.54744.47878.79761.56
Cash Growth
35.47%20.63%9.95%-15.28%15.39%-40.90%
Accounts Receivable
216.55202.39198.3177.8204.48274.36
Other Receivables
2.393.624.4618.1727.8113.57
Receivables
218.94206.02202.77195.97232.29287.93
Inventory
750.16512600.78691.6821.34714.77
Prepaid Expenses
---1.39--
Other Current Assets
100.1183.159597.58158.78182.1
Total Current Assets
1,9741,7891,7171,7312,0911,946
Property, Plant & Equipment
2,3402,4252,7162,9172,8572,604
Long-Term Investments
99.5999.8121.74170.23188.97196.16
Goodwill
222210.0110.01
Other Intangible Assets
307.84317.12363.56378.03406.14431.45
Long-Term Deferred Tax Assets
112.99120.4150.55152.14168.92118.34
Long-Term Deferred Charges
8.19.5610.6612.0819.516.51
Other Long-Term Assets
136.2798.25117.78116.25114.6108.75
Total Assets
4,9804,8615,2005,4795,8565,432

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
142.95121.07114.66122.3198.7137.87
Accrued Expenses
14.9133.0226.0931.2223.3833.79
Short-Term Debt
689.33551.38488.2341.89396.64246
Current Portion of Leases
-8.793.692.164.113.88
Current Income Taxes Payable
5.180.020.170.990.970.74
Current Unearned Revenue
30.8326.1729.8247.0151.3137.35
Other Current Liabilities
58.9262.2742.7157.7350.3339.3
Total Current Liabilities
950802.73705.34603.3725.43498.93
Long-Term Leases
23.6327.8617.381.172.582.15
Long-Term Unearned Revenue
8.3410.0614.9318.3923.1527.91
Long-Term Deferred Tax Liabilities
44.7246.3246.946.253.4129.29
Other Long-Term Liabilities
--12.99---
Total Liabilities
1,027886.97797.54669.05804.57558.28

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
2,0632,0632,0632,0632,0632,063
Additional Paid-In Capital
1,0191,0191,0191,0191,005998.96
Retained Earnings
968.58924.271,3041,6771,9351,889
Comprehensive Income & Other
-28.2227.9561.2776.5248.34-99.15
Total Common Equity
4,0224,0344,4474,8365,0514,851
Minority Interest
-69.28-60.24-45.23-26.030.2722.49
Shareholders' Equity
3,9533,9744,4024,8105,0514,874
Total Liabilities & Equity
4,9804,8615,2005,4795,8565,432

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
720.85588.03509.27345.21403.33252.04
Net Cash (Debt)
183.47399.38309.27399.25475.46509.53
Net Cash Growth
-43.10%29.13%-22.54%-16.03%-6.69%-38.28%
Net Cash Per Share
0.090.190.150.190.230.25
Filing Date Shares Outstanding
2,0692,0632,0632,0632,0632,063
Total Common Shares Outstanding
2,0692,0632,0632,0632,0632,063
Working Capital
1,024985.841,0121,1281,3661,447
Book Value Per Share
1.941.962.162.342.452.35
Tangible Book Value
3,7133,7154,0824,4564,6354,410
Tangible Book Value Per Share
1.791.801.982.162.252.14
Buildings
-1,8971,9331,9901,9261,740
Machinery
-1,7341,9141,8781,8961,224
Construction In Progress
-212.28174.58220.8952.92506.18